Finance

Lists
Why is NUVB down 5,68%?
Dive Deeper
NUVB:NYSE
Nuvation Bio Inc
4,48 USD
-5,68%
(-0,27) 1D
16-окт., 14:31:55 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NUVB...
Open
4,75 USD
High
4,76 USD
Low
4,46 USD
Mkt. cap
1,57 млд
Avg. vol.
5,41 млн
Volume
2,34 млн
52-wk high
9,75 USD
52-wk low
3,36 USD
EPS
-0,44 USD
Beta
1,61
Shares outstanding
351,12 млн
No. of employees
305
Open
4,75 USD
High
4,76 USD
Low
4,46 USD
Mkt. cap
1,57 млд
Avg. vol.
5,41 млн
Volume
2,34 млн
52-wk high
9,75 USD
52-wk low
3,36 USD
EPS
-0,44 USD
Beta
1,61
Shares outstanding
351,12 млн
No. of employees
305
News stories
From web sources and news partners
Simply Wall Street
Simply Wall Street
·
1 күн мурун
Top 3 Penny Stocks To Watch In October 2026
About Nuvation Bio Inc
CEODavid Hung
Employees305
Founded2018
Headquarters-
SectorPharmaceutical industry
Websitenuvationbio.com
Analyst ratings
Based on 9 analysts giving stock ratings to NUVB in the past 3 months
Strong buy
Buy
9
Hold
0
Sell
0
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for NUVB in the last 3 months.
Highest
Current 4,48 USD
21,00 USD (+368,75%)
Average
14,57 USD (+225,22%)
Lowest
11,00 USD (+145,54%)
Analyst
Recommendation
Action
Price target
Projected
Date
Geoff Meacham
Citi
Buy
Maintained
12,00 USD
+167,9%
10/15/2026
Leonid Timashev
RBC Capital
Buy
Maintained
20,00 USD
+346,4%
10/12/2026
Priyanka Grover
J.P. Morgan
Buy
Maintained
-
-
09/15/2026
David Nierengarten
Wedbush
Buy
Maintained
11,00 USD
+145,5%
09/15/2026
Gregory Renza
Truist Financial
Buy
Maintained
-
-
09/15/2026
Li Watsek
Cantor Fitzgerald
Buy
Initiated
12,00 USD
+167,9%
08/21/2026
Mayank Mamtani
B. Riley Securities
Buy
Maintained
14,00 USD
+212,5%
08/07/2026
Robert Burns
H.C. Wainwright
Buy
Reiterated
21,00 USD
+368,7%
08/07/2026
Boris Peaker
JonesTrading
Buy
Reiterated
12,00 USD
+167,9%
08/06/2026
Yaron Werber
TD Cowen
Buy
Reiterated
-
-
06/01/2026
Soumit Roy
JonesTrading
Buy
Maintained
12,00 USD
+167,9%
04/06/2026
Michael Yee
UBS
Hold
Maintained
7,00 USD
+56,2%
03/03/2026
Last report
2026-ж., 6-авг.
Fiscal period
Q2 2026
-0,15 USD / -0,12 USD
-25,15%miss
Revenue / Est. (USD)
31,69 млн / 28,70 млн
+10,42%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
13,12 млн
41,86 млн
83,23 млн
31,69 млн
Cost of goods sold
3,35 млн
1,28 млн
5,99 млн
9,47 млн
Cost of revenue
3,35 млн
1,28 млн
5,99 млн
9,47 млн
Research and development expenses
28,85 млн
34,30 млн
35,05 млн
30,66 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
37,36 млн
40,33 млн
38,31 млн
42,59 млн
Operating expense
66,20 млн
74,62 млн
73,36 млн
73,25 млн
Total operating expenses
69,55 млн
75,90 млн
79,35 млн
82,72 млн
Operating income
-56,43 млн
-34,04 млн
3,88 млн
-51,04 млн
Other non operating income
1,14 млн
-1,18 млн
3,11 млн
-179,00 миң
EBT including unusual items
-55,79 млн
-36,59 млн
5,40 млн
-62,84 млн
EBT excluding unusual items
-55,80 млн
-36,59 млн
5,39 млн
-53,38 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-55,79 млн
-36,59 млн
5,40 млн
-62,84 млн
Net profit margin
-425,24%
-87,40%
6,48%
-198,31%
Earnings per share
-0,14
-0,09
0,04
-0,15
Interest and investment income
6,03 млн
5,30 млн
5,11 млн
4,60 млн
Interest expense
-6,53 млн
-6,67 млн
-6,71 млн
-6,76 млн
Net interest expenses
-501,00 миң
-1,38 млн
-1,60 млн
-2,16 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-55,90 млн
-33,50 млн
4,42 млн
-50,50 млн
Gain or loss from assets sale
-4,00 миң
3,00 миң
-
-1,00 миң
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google колдонмолору